Exchange transfusion in the management of critical pertussis in young infants: a case series

Pham Thai Son1, Abdullah Reda2, Do Chau Viet1

  • 1Department of Infectious Diseases, Children's Hospital No.2, Ho Chi Minh, Vietnam.

Vox Sanguinis
|May 18, 2021
PubMed

Insights

Early exchange transfusion (ET) can be a life-saving treatment for severe pertussis (whooping cough) in children. This procedure rapidly reduces high white blood cell counts, preventing critical complications.

Area of Science:

  • Pediatric Infectious Diseases
  • Hematology
  • Critical Care Medicine

Background:

  • Severe leucocytosis in pertussis (whooping cough) is linked to pulmonary hypertension and restricted blood flow.
  • Exchange transfusion (ET) is a recognized method for reducing high white blood cell counts.

Purpose of the Study:

  • To evaluate the effectiveness of exchange transfusion (ET) in managing severe pertussis-induced respiratory distress.
  • To analyze cases of pertussis complicated by severe leucocytosis.

Main Methods:

  • Retrospective case series of four pediatric pertussis patients with severe leucocytosis and respiratory distress requiring mechanical ventilation.
  • PCR confirmation of pertussis infection.
  • Assessment of outcomes following exchange transfusion.

Main Results:

  • Three patients underwent double volume ET for leucodepletion.
  • Two patients treated with ET showed positive outcomes with discharge.
  • One patient died despite late ET; another patient who did not receive ET also died.

Conclusions:

  • Early exchange transfusion (ET) shows promise as a rapid, life-saving intervention for critical pertussis with severe leucocytosis.
  • Timely ET may prevent the development of cardiopulmonary complications in pediatric pertussis patients.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
540
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
599
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
313
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
439
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
498